To determine whether leukocytes express the angiotensinogen gene, we subjected circulating rat leukocytes and murine bone marrow cells to Northern blot analysis and hybridization with homologous angiotensinogen complementary DNA. Angiotensinogen messenger RNA sequences were detected in circulating adult rat leukocytes, in murine-irradiated and nonirradiated bone marrow stromal cells, and in an adherent stromal cell line (preadipocyte). Western blot analysis of rat leukocyte homogenate showed that rat leukocytes contain two main angiotensinogen isoforms with approximate molecular weights of 46.5 and 53.9 kd. Synthesis and release of angiotensinogen protein by rat leukocytes was confirmed by immunoprecipitation of radiolabeled angiotensinogen from cell lysate and media of rat leukocytes that were metabolically labeled with M S-L-methionine. In addition, the angiotensinogen protein present in media of rat leukocytes was enzymatically cleaved by hog renin, resulting in generation of angiotensin I (305±47 pg angiotensin I per milliliter of media per hour). We conclude that circulating rat leukocytes express the angiotensinogen gene and synthesize and release angiotensinogen with the capability to generate angiotensin. Expression of angiotensinogen by leukocytes may provide a mobile angiotensingenerating system of potential importance in the regulation of local inflammatory responses, tissue injury (i.e., myocardial infarction), and arterial hypertension. 
I
n the traditional view of the circulating reninangiotensin system, renin is released by the kidney and, within the bloodstream, acts on circulating angiotensinogen to generate angiotensin I (Ang I), which is hydrolyzed subsequently to angiotensin II (Ang II) by the action of Ang I converting enzyme.
-
2 In addition to this circulating renin-angiotensin system, it has been suggested that local renin-angiotensin systems exist that may regulate tissue functions by the paracrine or autocrine actions of Ang II produced and delivered locally or intracellularly. 34 The prohormone angiotensinogen is the only known precursor of angiotensin peptides. Thus, demonstration of its local synthesis by a particular tissue constitutes presumptive evidence for the presence of a local angiotensin-generating system. Recently, Wintroub and colleagues 5 -6 demonstrated that human granulocytes contain cathepsin G, a lysosomal neutral protease that converts Ang I to Ang II and is capable of cleaving Ang II directly from plasma angiotensinogen, at least in vitro. Mononuclear leukocytes contain and release angiotensin. 7 ' 8 In addition, macrophages contain angiotensin converting enzyme and synthesize angiotensins. 910 Thus, it seems that white blood cells possess the machinery to generate angiotensin peptides locally. It remains to be determined, however, whether leukocytes express the angiotensinogen gene and synthesize and release angiotensinogen. Local generation of Ang II in a tissue undergoing an inflammatory response might modulate tissue blood flow, vascular permeability, and granulomatous responses. 11 -13 In addition, the local angiotensin-generating system may be critical to the suggested role of leukocytes in hypertension and cardiovascular injury. 14 -18 Although constitutive secretion of angiotensinogen by the liver assures a constant supply of circulating angiotensinogen, the concentration of this protein in the interstitium of different organs is not known. A more effective and efficient mechanism of delivering angiotensinogen to a target tissue (i.e., during inflammation) could be achieved through mobile blood-borne cells, capable of releasing and processing the peptide on demand. This notion is supported by the present study, which demonstrates that circulating leukocytes contain, synthesize, and release angiotensinogen. In addition, we document the expression of angiotensinogen transcripts in murine bone marrow stromal cells.
Methods

Circulating Rat Leukocytes
Thirty-three rats (seven Wistar, 26 Sprague-Dawley) weighing between 100 and 350 g were obtained from the University of Virginia vivarium and were anesthetized with halothane. Approximately 8 mL blood was drawn by direct heart puncture into heparinized syringes, transferred to heparinized tubes, and centrifuged (l,600g, 4"C, 10 minutes) in a clinical centrifuge (International Equipment Co., Needham Heights, Mass.). The white cell layer (buffy coat) was removed, pooled, snap frozen in liquid nitrogen, and kept at -80°C until processing for angiotensinogen messenger RNA (mRNA) determinations as described below. A differential of Wright-stained buffy coat of rat blood showed the leukocytes to be ^95% mononuclear cells.
Murine Bone Marrow Cells
Murine long-term marrow cultures were established as previously described 19 from 6-12-week-old female BALB/c mice (Charles River Laboratories, Inc., Boston) in 25-or 75-cm flasks using 10 or 30 mL Fischer's medium with 10~7 M hydrocortisone, 20% horse serum, and penicillin/streptomycin/fungizone. The marrow contents of one tibia and femur was cultured in 10 mL medium. The cultures were incubated at 33°C and 5% CO 2 and refed weekly by demidepopulation. At week 4 of culture, some flasks were exposed to gamma irradiation (1,100 cGy) from a cesium source (Gamma cell 40 irradiator, Atomic Energy of Canada, Ltd., Ontario, Canada) delivering 120-128 cGy/min. The medium from the irradiated cultures and unirradiated control cultures was then totally removed and replaced with fresh medium. Three days later, cell media and remaining nonadherent cells were removed, and fresh medium was added to the adherent cells. Sixteen hours later, the medium was removed, and the cells were lysed in guanidinium isothiocyanate for RNA purification and analysis. TC-1 is a murine stromal cell line isolated from C57BL/6J murine long-term marrow cultures by sequential trypsinization and force passage in Fischer's medium supplemented with 20% fetal calf serum and penicillin and streptomycin. It consists of alkaline phosphatase-positive preadipocytic fibroblasts. 20 Bac-1 is a colony stimulating factor (CSF)-l-dependent murine macrophage cell line. Irradiated stroma is composed of 70-80% macrophages, 10-20% preadipocytic fibroblasts, and a smaller percent of other cells, including factor Vlll-positive endothelial cells. Nonirradiated stroma is composed of the cells mentioned above plus a large number of neutrophilic granulocytes and a small number of megakaryocytes.
Extraction, Electrophoresis, and Hybridization of RNA to Complementary DNAs
Total RNA from circulating leukocytes and the indicated cell lines was extracted as previously described. 21 " 23 Polyadenylated RNA was prepared by chromatography on oligo (dT)-cellulose as described by Maniatis et al. 24 The extracted RNA was dissolved in sterile water and stored at -80°C until use. RNA concentrations were determined spectrometrically at 260 nm. RNA was denatured by heating for 10 minutes at 65°C in 4.4 M formaldehyde/50% formamide and was resolved by electrophoresis on 1.0% agarose gels containing 2.2 M formaldehyde. The RNA was transferred to a positively charged nylon 66 membrane (Zetabind, AMF Cuno, Meriden, Conn.) by capillary action. The bound RNA was heated in vacuo at 80°C for 2 hours, exposed to ultraviolet light for 1 minute, dried, and stored until hybridization. Northern blots were hybridized by the method of Church and Gilbert 25 as we described previously.
22
- 23 Blots containing RNA from circulating rat leukocytes and murine bone marrow cells were hybridized to full-length rat angiotensinogen complementary DNAs (cDNAs). 26 Probes were labeled with phosphorus-32 by nick translation to specific activities above 2x 10 s dpm/^ig. 27 Signals were detected by contact autoradiography in the presence of an image-intensifying screen.
Detection of Intracellular Angiotensinogen by Western Blot Analysis
To determine whether circulating leukocytes contain angiotensinogen, we separated rat leukocytes from erythrocytes by centrifugation in a colloidal silica-based medium (Sepracell MN, Sepratech, Oklahoma City, Okla.) and washed them repeatedly with homogenization buffer [250 mM sucrose, 50 mM 2-(/V-morpholino)ethanesulfonic acid, 1 mM EDTA, pH 7.2] to remove Sepracell and plasma proteins. The washed leukocytes were resuspended in 1 mL homogenization buffer and disrupted by sonication (40 pulses; setting 3; duty cycle, 30%) with a sonifier (Branson Ultrasonics Corp., Danbury, Conn. 28 Separated proteins were transferred to nitrocellulose and processed by a standard immunoblotting technique 29 using a primary polyclonal antibody to rat angiotensinogen (gift of Dr. P. Corvol, INSERM U-36, Paris) that was identified with a goat anti-rabbit secondary antibody conjugated to alkaline phosphatase (Promega, Fisher, Columbia, Md.).
Detection of Angiotensinogen Synthesis by Rat Leukocytes
Rat leukocytes were separated from 8-12 mL heparinized rat blood by centrifugation through Histopaque (Sigma Chemical Co., St. Louis, Mo.). Briefly, 3-4 mL heparinized rat blood was layered onto a discontinuous gradient of 3 mL Histopaque 1083 and 3 mL Histopaque 1119. Samples were centrifuged (TJ6 centrifuge, Beckman Instruments, Inc., Fullerton, Calif.) for 30 minutes at 70Qg at room temperature, and rat white cells were recovered as a distinct band at the interface of rat serum and Histopaque 1083. The white cells were combined and washed with 50 mL labeling medium (L-methionine-deficient RPMI 1640 containing 0.2% bovine serum albumin [radioimmunoassay grade] and 25 mM HEPES, pH 7.4). Steady-state metabolic labeling of rat leukocytes was performed by resuspending rat leukocytes in 2.5 mL labeling medium that also contained 1 mCi 35 S-L-methionine, translational grade (New England Nuclear, Boston), and 5 ^ig concanavalin A (Sigma). Cells were maintained in this metabolic-labeling medium for 16-18 hours with shaking at 37°C.
Viability of rat leukocytes was followed by trypan blue exclusion. At least 90% of leukocytes remained viable for the 16-18 hours of metabolic labeling. Hematoxylin staining of leukocytes used in metabolic-labeling studies showed that this population of cells was ^95% mononuclear.
After metabolic labeling, medium and cells were separated by centrifugation at l,000g for 5 minutes. Medium was combined with an equal volume of immu- ], 20 mM Tris-HCl, 280 mM NaCl, 5 mM EDTA, and 10 mM methionine, pH 7.6). Cell pellets were combined with 0.5 mL immunoprecipitation buffer and sonicated as described for immunoblotting and then diluted with an equal volume of deionized water. Cell h/sate was centrifuged (Eppendorf microfuge) at 14,000 rpm for 10 minutes to remove cell membranes before immunoprecipitation.
Immunoprecipitation of leukocyte angiotensinogen was done by the method of Campbell et al. 30 Briefly, cell lysate (500 pL) and leukocyte-labeling medium (1 mL) were preabsorbed against a 100 -fiL suspension of staphylococcal protein A cross-linked to agarose (Sigma) for 2 hours at 4°C. The preabsorbed medium and cell lysate was then combined with a suspension (50-100 fiL) of angiotensinogen antibody (gift of Dr. Christopher Klett and Ulrich Hilgenfeldt, Heidelberg, FRG) cross-linked to Reactigel (Pierce Chemical Co., Rockford, 111.).
In some immunoprecipitation tubes, 2 mg/mL rat immunoglobulin was added to test specificity of binding. In other samples, partially purified angiotensinogen from nephrectomized rat plasma (1 mL) was added to compete with radiolabeled angiotensinogen for antibody binding. After 4 hours of incubation at 4°C, supernatant was removed and the immunoprecipitate was washed four times with 1 mL per wash of immunoprecipitation buffer diluted 1:1 with deionized water. Immunoprecipitated angiotensinogen was eluted from antibody cross-linked to Reactigel by the addition of 75 IML per tube of stop solution and boiling for 5 minutes. Denatured immunoprecipitation samples were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The immunoprecipitated labeled angiotensinogen was detected by autoradiography of dried gels.
Generation of Angiotensin I
Angiotensinogen concentration in media from rat leukocytes was indirectly determined by incubation with excess hog renin (Sigma) for 90 minutes at 37°C as previously described. 31 Ang I generated by this incubation was measured by radioimmunoassay. It is expressed as picograms Ang I per milliliter of media per hour and represents the mean±SEM for three determinations. Control incubations were done in the absence of hog renin.
Results
The detection of angiotensinogen transcripts in various rat tissues is shown in Figure 1 . The representative autoradiogram demonstrates the presence of angiotensinogen mRNA sequences in poly A(+)-enriched RNA from rat circulating leukocytes (Figure 1, A+ ). An intense hybridization signal with a similar electrophoretic mobility (arrow, 1.8 kb) to that of angiotensinogen mRNA from adult rat liver (Figure 1, L) was observed. A similar hybridization signal, although less intense, was observed in the lane corresponding to the neonatal kidney (Figure 1, NK) . No hybridization signals were observed in the poly A ( -) RNA fraction from circulating rat leukocytes (Figure 1, A-) .
Western blotting of angiotensinogen from rat leukocyte homogenate demonstrated the presence of angio-
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FIGURE 1. Northern blot shows autoradiographic detection of angiotensinogen messenger RNA sequences in circulating rat white blood cells. NK, total RNA (5 fig) from 5-day-old kidney; L, total RNA (2 fig) from adult rat liver; A -, poly A(-) RNA fraction (6 ng) from rat leukocytes; A+, poly A(+)-enriched RNA fraction (6 fig) from rat leukocytes.
Angiotensinogen RNA sequences were visualized by autoradiography after hybridization to 100 ng 32 
P-labeled rat angiotensinogen complementary DNA (specific activity, 7xlO s cpmliig). Exposure time, 2 days; Kodak RP film with intensifying screen. Angiotensinogen sequences (arrow, 1.8 kb) are detected in neonatal kidney, adult liver, and poly A(+) RNA from circulating leukocytes.
tensinogen protein (Figure 2, lane 1) . Two major bands (estimated M r , 46.5 and 53.9 kd) were identified that correspond in size to that of angiotensinogen partially purified from plasma of nephrectomized rats (lane 3) and rat liver homogenate (lane 4). Erythrocytes (lane 2) did not contain immunoreactive angiotensinogen.
Synthesis and release of angiotensinogen by rat leukocytes was documented by immunoprecipitation of radiolabeled angiotensinogen from the cell lysate and media of rat leukocytes that were metabolically labeled with ^S-L-methionine. The major form of radiolabeled angiotensinogen immunoprecipitated from cell lysate had an estimated M r of 47 kd (Figure 3, lane 1) . The major angiotensinogen forms immunoprecipitated from media had apparent M, values of 47 and 90 kd ( Figure 3,  lane 2) . The presence of the high molecular weight form of angiotensinogen in the media suggests the presence of a multimeric form of angiotensinogen. The immunospecific binding of radiolabeled angiotensinogen from cell lysate was competed substantially by excess partially purified rat angiotensinogen (Figure 3, lane 3) . The immunospecific binding of radiolabeled angiotensinogen in media was competed totally by excess partially purified rat angiotensinogen (Figure 3, lane 4) . Radiolabeled angiotensinogen specific binding was not competed by rat immunoglobulin in cell lysate or media (data not shown).
Further confirmation of the release of angiotensinogen by rat leukocytes was shown when media from rat leukocytes was incubated with hog renin. An increase in 
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measurable Ang I was generated by the hog renin's specific enzymatic action on angiotensinogen substrate in leukocyte media (305 ±47 versus 82 ±10 pg Ang I per milliliter of media per hour, hog renin versus no hog renin, n=3). Figure 4 shows the detection of angiotensinogen mRNA in murine stromal white cells. Angiotensinogen mRNA was detected in irradiated (IBMS) and nonirradiated (BMS) bone marrow stromal cells. Angiotensinogen mRNA accumulation was higher in unirradiated than in irradiated cells (Figure 4) . Angiotensinogen mRNA transcripts were also present (although at lower levels) in adherent preadipocyte stromal cell line (TCI, Figure 4 ). Angiotensinogen mRNA was not detected in CSF-dependent macrophages (BAC-1) or mast cells (NC6) (Figure 4 ).
Discussion
The present study demonstrates that circulating rat leukocytes express the angiotensinogen gene and contain, synthesize, and release immunoreactive angiotensinogen capable of generating Ang I on incubation with exogenous renin. In addition, we show that bone marrow-derived murine stromal cells express the angiotensinogen gene.
Previous studies have demonstrated that other components of a putative angiotensin-generating system are present in circulating leukocytes. 5 " 9 Monocytes are known to contain angiotensin converting enzyme. 9 Human neutrophils contain cathepsin G, a lysosomal neutral protease that can convert Ang I to Ang II and cleaves Ang II directly from plasma angiotensinogen. Although the synthesis of renin by leukocytes has not yet been described, it appears that most of the components of the renin-angiotensin system are produced by circulating white blood cells. Thus, in addition to the traditional plasma-borne (endocrine) renin-angiotensin system, leukocytes may mediate a compartmentalized angiotensin system. White blood cells are able to synthesize, presumably store, and transport components of the system and may be able to generate angiotensin or angiotensins in target tissues. Although the physiological significance of these findings remains to be determined, it is possible that local generation of Ang II by infiltrating leukocytes may play a key role in inflammation and tissue repair and injury. In this regard, Ang II increases vascular permeability and fluid filtration across capillaries 1112 and induces shape changes in endothelial cells, leading to a widening of interendothelial spaces and increased vascular permeability.
11
The synthesis of the prohonnone angiotensinogen by circulating cells that have the capability to penetrate and reside in the interstitium of different organs would provide a very efficient mechanism for the delivery of angiotensin peptides to a localized area of injury or inflammation.
Leukocyte infiltration is a common finding in atherosclerosis and vascular injury due to hypertension. 16 -17 In addition, leukocytes have been implicated in the injury resulting from ischemia-reperfusion in the heart and other organs. 14 The role of the leukocyte renin-angiotensin system in the aforementioned disease processes remains to be explored. Immune mechanisms may play a role in the initiation and maintenance of various forms of human and experimental hypertension. 18 More recently, elevated leukocyte counts have been found in spontaneously hypertensive rats when compared with their control Wistar-Kyoto rats.
14 Thus, the available evidence suggests that white blood cells may be involved in cardiovascular pathology, including hypertension. The contribution of the putative leukocyte angiotensingenerating system to the aforementioned pathologies needs to be elucidated.
Although more than 95% of cells in these studies were mononuclear cells, the identity of the specific type of circulating leukocyte responsible for angiotensinogen synthesis remains to be determined. Carefully performed in situ hybridization studies may help to resolve this question. The present study also provides evidence for the expression of angiotensinogen by bone marrow-derived stromal cells. These findings are in close agreement with those of Gimble et al, 32 who reported expression of angiotensinogen gene in cloned bone marrow stromal cells. Stromal cells establish and provide the microenvironment necessary for proliferation and differentiation of circulating blood cells. 33 In this regard, it should be noted that adipocytes also express the angiotensinogen gene. 34 - 37 The function of locally generated angiotensinogen by bone marrow stromal cells is not known. However, because angiotensins are known to induce growth responses, 38 -39 it is tempting to speculate that locally generated angiotensinogen within the bone marrow microenvironment may play a role in hematopoiesis.
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Finally, the present study demonstrates the presence and release of immunoreactive isoforms of angiotensinogen in rat circulating leukocytes. The observed range of estimated molecular weights of immunoreactive angiotensinogen protein in leukocytes, plasma, and liver may be explained by the well-known heterogeneity in the carbohydrate composition of rat angiotensinogen and multimeric forms of angiotensinogen as previously described.*°- 41 The physiological significance of the aforementioned differences remains to be defined.
In summary, the present study demonstrates that circulating rat leukocytes express the angiotensinogen gene and contain and synthesize immunoreactive angiotensinogen species capable of generating angiotensins in the basal state and after incubation with renin. A leukocyte angiotensin-generating system may be important in the modulation of inflammatory responses, tissue injury, and cardiovascular pathology such as hypertension.
